Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 193.00
-1.00 (-0.52%)
Aug 28, 2026, 1:30 PM CST
Lotus Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,325 | 7,740 | 6,030 | 1,771 | 1,983 | 1,605 |
Cash & Short-Term Investments | 6,325 | 7,740 | 6,030 | 1,771 | 1,983 | 1,605 |
Cash Growth | 53.78% | 28.35% | 240.51% | -10.71% | 23.54% | 7.82% |
Accounts Receivable | 8,618 | 6,863 | 7,435 | 6,384 | 4,651 | 3,266 |
Other Receivables | 518.54 | 936.56 | 268.54 | 233.13 | 276.24 | 141.56 |
Receivables | 9,136 | 7,799 | 7,703 | 6,617 | 4,927 | 3,407 |
Inventory | 8,899 | 9,649 | 3,833 | 3,775 | 3,330 | 3,073 |
Other Current Assets | 1,299 | 1,264 | 531.5 | 489.37 | 420.4 | 247.24 |
Total Current Assets | 25,659 | 26,453 | 18,098 | 12,653 | 10,661 | 8,333 |
Property, Plant & Equipment | 7,572 | 7,607 | 3,666 | 3,511 | 3,148 | 2,642 |
Long-Term Investments | 478.1 | 463.88 | 3,594 | 3,048 | 2,158 | 301.73 |
Goodwill | 32,131 | 31,955 | 6,127 | 5,670 | 5,668 | 5,586 |
Other Intangible Assets | 11,789 | 12,204 | 5,199 | 5,487 | 5,910 | 2,971 |
Long-Term Accounts Receivable | 97.34 | 113.85 | 122.73 | 152.6 | - | - |
Long-Term Deferred Tax Assets | 14,256 | 13,942 | 486.42 | 411.69 | 390.12 | 310.82 |
Long-Term Deferred Charges | 14,886 | 13,119 | 2,639 | 1,878 | 1,406 | 891.98 |
Other Long-Term Assets | 1,717 | 295.86 | 168.74 | 180.28 | 185.33 | 185.35 |
Total Assets | 108,586 | 106,154 | 40,101 | 32,992 | 29,526 | 21,222 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,790 | 2,416 | 1,070 | 670.8 | 1,403 | 747.55 |
Accrued Expenses | 2,210 | 2,851 | 1.4 | 3.06 | 3.57 | 0.93 |
Short-Term Debt | 1,897 | 1,609 | 1,615 | 510 | 155.92 | 1,377 |
Current Portion of Long-Term Debt | 3,761 | 2,541 | 3,390 | 1,303 | 59.95 | 794.9 |
Current Portion of Leases | 163.44 | 159.63 | 84.32 | 70.24 | 58.99 | 62.47 |
Current Income Taxes Payable | 931.7 | 1,416 | 664.47 | 436.56 | 731.15 | 280.16 |
Current Unearned Revenue | 139.56 | 179.16 | 180.9 | 132.85 | 183.08 | 132.01 |
Other Current Liabilities | 5,629 | 5,707 | 1,432 | 1,398 | 3,297 | 931.26 |
Total Current Liabilities | 17,522 | 16,879 | 8,438 | 4,524 | 5,893 | 4,326 |
Long-Term Debt | 51,906 | 50,905 | 8,384 | 9,519 | 8,596 | 4,667 |
Long-Term Leases | 718.13 | 718.62 | 194.06 | 182.2 | 46.82 | 43.41 |
Long-Term Unearned Revenue | 11.76 | 16.29 | 26.56 | 45.33 | 65.92 | 85.96 |
Pension & Post-Retirement Benefits | 774.87 | 767.52 | 673.52 | 503.28 | 371.91 | 502.7 |
Long-Term Deferred Tax Liabilities | 1,789 | 1,697 | 1,093 | 721.2 | 448.4 | 304.15 |
Other Long-Term Liabilities | 11,558 | 11,390 | 112.17 | 162.29 | 235.84 | 224.03 |
Total Liabilities | 84,280 | 82,374 | 18,921 | 15,658 | 15,658 | 10,153 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,703 | 2,669 | 2,659 | 2,650 | 2,626 | 2,628 |
Additional Paid-In Capital | 7,631 | 7,642 | 7,431 | 7,131 | 7,534 | 8,039 |
Retained Earnings | 16,405 | 15,904 | 12,660 | 8,900 | 4,823 | 1,701 |
Treasury Stock | -824.2 | -824.16 | -48.39 | -51.1 | -57.35 | -57.75 |
Comprehensive Income & Other | -1,610 | -1,610 | -1,521 | -1,295 | -1,058 | -1,241 |
Total Common Equity | 24,305 | 23,780 | 21,180 | 17,334 | 13,868 | 11,069 |
Shareholders' Equity | 24,305 | 23,780 | 21,180 | 17,334 | 13,868 | 11,069 |
Total Liabilities & Equity | 108,586 | 106,154 | 40,101 | 32,992 | 29,526 | 21,222 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 58,446 | 55,934 | 13,667 | 11,585 | 8,918 | 6,944 |
Net Cash (Debt) | -52,121 | -48,194 | -7,636 | -9,814 | -6,935 | -5,339 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -199.55 | -184.20 | -28.99 | -37.45 | -26.50 | -20.80 |
Filing Date Shares Outstanding | 266.23 | 262.81 | 265.39 | 264.47 | 262.04 | 262.25 |
Total Common Shares Outstanding | 266.23 | 262.81 | 265.39 | 264.47 | 262.04 | 262.25 |
Working Capital | 8,137 | 9,574 | 9,660 | 8,129 | 4,768 | 4,007 |
Book Value Per Share | 91.30 | 90.48 | 79.81 | 65.54 | 52.92 | 42.21 |
Tangible Book Value | -19,614 | -20,380 | 9,855 | 6,177 | 2,291 | 2,512 |
Tangible Book Value Per Share | -73.68 | -77.54 | 37.13 | 23.36 | 8.74 | 9.58 |
Land | 608.15 | 624.65 | 599.33 | 622.55 | 622.31 | 615.49 |
Buildings | 4,062 | 4,031 | 2,074 | 1,888 | 1,384 | 1,313 |
Machinery | 3,693 | 3,622 | 1,865 | 1,826 | 1,547 | 1,408 |
Construction In Progress | 743.44 | 657.97 | 706.38 | 639.41 | 1,077 | 675.22 |
Leasehold Improvements | 145.3 | 127.33 | 100.15 | 71.01 | 87.87 | 78.26 |